drugset / Trial / NCT06403488
Letrozole Dose Increments in PCOS Patients Resistant to Letrozole
RandomizedParallel-groupOpen-labelTreatment
Summary
Objectives: To study the effect of Letrozole dose increments on ovulation rate and endometrial thickness as a primary outcomes in patients with polycystic ovary syndrome who previously resistant to letrazole conventional dose, and chemical and clinical pregnancy considered as secondary outcomes.
Timeline
- Start
- 2023-10-01
- Primary completion
- 2024-01-30
- Completion
- 2024-01-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Letrozole | Other / unclassified | 7.5 mg | — |
| Subject | Letrozole | Other / unclassified | 10 mg | — |